UniFirst Corporation (NYSE:UNF) report Q3 earnings of $2.46 per share

UniFirst Corporation (NYSE:UNF) reported third-quarter earnings of $2.46 per share, which beat the analyst consensus estimate of $1.69. This is a 55.7% increase over earnings of $1.58 per share from the same period last year. The company reported quarterly sales of $453.72 million, which beat the analyst consensus estimate of $441.7 million. This is a 6.16% increase over sales of $427.384 million the same period last year. The company sees FY2019 EPS of $8.75-$8.85 compared to the $7.96 estimate.



UniFirst Corporation (NYSE:UNF) shares climbs 6.92% to finally closed at $178.11 in last active session. 

UNF’s distance from 20 day simple moving average is 8.17% and distance from 50-Day simple moving average is 10.28%.

Analyst’s mean target price for UNF is $165.00. Stock value has moved between $131.93 – 193.6 in last one year. Stock has got OUTPERFORM rating from 0 of Thomson Reuters analysts, 3 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for UNF is $165.00. 

UniFirst Corporation (NYSE:UNF) yearly performance is -1.60% and net profit margin is 9.00%. Annual EPS Growth of past 5 years is 4.40%. The current share price indicates that stock is -7.74% away from its one year high and is moving 34.54% ahead of its 52-week low. 



On 26 June 2018, The Williams Companies, Inc. (NYSE:WMB) shares climbs 2.65% and ultimately finalized to $27.50 in last traded day. Stock has got OUTPERFORM rating from 10 of Thomson Reuters analysts, 2 given HOLD rating to the stock and 0 given UNDERPERFORM rating. Analyst’s mean target price for WMB is $31.95 while analysts mean recommendation is 1.70. 



At the movement Gilead Sciences, Inc. (NASDAQ:GILD) is under coverage by number of analysts. Buy rating has been given by 8 analysts to the company stock whereas 1 given UNDERPERFORM rating to stock and 9 given HOLD rating. The consensus recommendation by Thomson Reuters analysts is outperform and their mean rating for the stock is 2.11 on scale of 1-5. Analysts mean target price for Gilead Sciences, Inc. (NASDAQ:GILD) is $79.81 while their mean recommendation is 2.20 (1=Buy, 5=sell). 

If we look at stock performance in last active day trading, we see that stock has moved slumped -2.63% to end the day at $66.68. The current share price indicate that stock is -16.24% away from its one year high and is moving 10.54% ahead of its 52-week low. 

Leave a Reply